Crossmark

Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC

Crossref DOI link: https://doi.org/10.1186/S12885-018-5005-2

Published: 2018-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Chua, Kevin Lee Min

Yeo, Eugenia Li Ling

Shihabudeen, Waseem Ahamed

Tan, Sze Huey

Shwe, Than Than

Ong, Enya Hui Wen

Lam, Paula Yeng Po

Soo, Khee Chee

Soong, Yoke Lim

Fong, Kam Weng

Tan, Terence Wee Kiat

Wee, Joseph Tien Seng

Chua, Melvin Lee Kiang http://orcid.org/0000-0001-6021-368X
Funding

Funding for this research was provided by:

National Medical Research Council (#NMRC/TA/0030/2014)

Duke-NUS Oncology Academic Program Proton Research Program (08/FY2017/EX/06-A37)
License Information

Text and Data Mining valid from 2018-11-12
More Information

Article History

Received: 1 May 2018

Accepted: 29 October 2018

First Online: 12 November 2018

Ethics approval and consent to participate

: This study was approved by the ethics committee of the SingHealth Centralised Institutional Review Board (CIRB Ref: 2003/419/B). All the patients enrolled in this study have provided written informed consents for specimen collection and anonymous participation in the research.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below